Clincosm LogoSign in Get a demo

neurofibromatosis type 2

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis Type 2 Trial in United States (REC-2282, Placebo)

Recruiting
  • Neurofibromatosis Type 2
  • Los Angeles, California
  • +11 more
Aug 5, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Neurofibromatosis Type 2, Neuroma, Acoustic Trial in Los Angeles (RAD001, everolimus)

Active, not recruiting
  • Neurofibromatosis Type 2
  • Neuroma, Acoustic
  • RAD001, everolimus
  • Los Angeles, California
    University of California Los Angeles
Mar 2, 2022

Neurofibromatosis Type 2, Vestibular Schwannomas Trial in New York (Axitinib)

Completed
Has Results
  • Neurofibromatosis Type 2
  • Vestibular Schwannomas
  • New York, New York
    NYU Langone Medical Center
Nov 24, 2021

Vestibular Schwannoma, Neurofibromatosis Type 2 Trial in Beijing (Icotinib)

Completed
  • Vestibular Schwannoma
  • Neurofibromatosis Type 2
  • Beijing, Beijing, China
  • +1 more
Sep 8, 2021

Neurofibromatosis Type 2, Progressive Vestibular Schwannomas Trial in United States (Bevacizumab)

Completed
Has Results
  • Neurofibromatosis Type 2
  • Progressive Vestibular Schwannomas
  • Los Angeles, California
  • +11 more
Jan 26, 2021

Neurofibromatosis Type 2, Vestibular Schwannomas, Meningiomas Trial in New York (RAD001)

Completed
  • Neurofibromatosis Type 2
  • +2 more
  • New York, New York
    New York University School of Medicine
May 12, 2020

Neurofibromatosis Type 2 Trial in Manchester (MR imaging)

Completed
  • Neurofibromatosis Type 2
  • MR imaging
  • Manchester, Manchester (Manchester Borough), United Kingdom
    Central Manchester University Hospitals NHS Foundation Trust
Mar 16, 2020

Neurofibromatosis Type 2, Severe Profound Sensorineural Hearing Loss Trial in Boston (Nucleus Profile ABI541 Auditory Brainstem

No longer available
  • Neurofibromatosis Type 2
  • Severe Profound Sensorineural Hearing Loss
  • Nucleus Profile ABI541 Auditory Brainstem Implant
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Dec 4, 2019

Vestibular Schwannoma, Neurofibromatosis Type 2 Trial in Baltimore, Rockville, Charlestown (biological, other, procedure)

Completed
Has Results
  • Vestibular Schwannoma
  • Neurofibromatosis Type 2
  • bevacizumab
  • +2 more
  • Baltimore, Maryland
  • +2 more
Jul 27, 2018

Vestibular Schwannoma, Neurofibromatosis Type 2 Trial in Beijing (Endostatin)

Completed
  • Vestibular Schwannoma
  • Neurofibromatosis Type 2
  • Beijing, Beijing, China
    Beijing Tiantan Hospital Affiliated to Capital Medical Universit
Feb 7, 2017